Post-earnings recap
Reported
Thu, Mar 25, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
38%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Immunome Inc's earnings report shows a loss per share of $0.40, with no revenue figures disclosed. The stock reacted negatively, declining by 1.18%. Investors may be concerned about the lack of financial clarity and guidance from management, which could impact future expectations.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.40 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Management acknowledged the challenges faced during the quarter. They emphasized their commitment to progressing their research initiatives.
Management did not provide specific revenue figures for the quarter.
The company is focused on advancing its pipeline despite the current financials.